JPMorgan increased its holdings in Huaqin Co., Ltd. (03296) by 200,200 shares at a price of approximately HKD 62.63 per share.
On July 30, JPMorgan Chase increased its holdings in Maxscend Technologies (03296) by 200,200 shares, at a price of HK$62.6322 per share, for a total amount of approximately HK$12.539 million.
The latest data from the Hong Kong Stock Exchange shows that on July 30, JPMorgan Chase increased its holdings in Huaqin Co., Ltd. (03296) by 200,200 shares, at a price of HKD 62.6322 per share, totaling approximately HKD 12.539 million. After the increase, the latest number of shares held is approximately 15.2659 million, with a new ownership ratio of 16.19%.
Related Articles
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
RECOMMEND
